Cerebral venous thrombosis accounts for 0.5% to 3% of all strokes. The most vulnerable
populations include young individuals, women of reproductive age, and patients with a …

The onset of CVT can span from acute to subacute, and even chronic presentations, with
symptoms that are more varied than other stroke types and often nonspecific, which may …

Background: The efficacy and safety of dabigatran etexilate for Chinese patients with
cerebral venous thrombosis (CVT) has not been well established. Methods: CHOICE-CVT …

Background There is an unmet need for high-quality data from prospective studies on the
safety and effectiveness of direct oral anticoagulants (DOACs) for the treatment of cerebral …

The 7th edition of the Canadian Stroke Best Practice Recommendations (CSBPR) is a
comprehensive summary of current evidence-based recommendations, appropriate for use …

CVT is an unusual type of cerebrovascular disease that mostly affects women of fertile age.
Risk factors should be identified and addressed. Diagnosis relies on confirmation of venous …

Background: Cerebral venous thrombosis (CVT) is a rare but severely disabling form of
stroke. Acute treatment mainly consists of medical management, since there is no robust …

Background: Cerebral venous thrombosis (CVT) is a rare but severely disabling form of
stroke. Acute treatment mainly consists of medical management, since there is no robust …

BACKGROUND: Lack of a dedicated thrombectomy device for cerebral venous thrombosis
hinders the recanalization ability of endovascular treatment (EVT). Novel NiTi-braided stent …

Background Cerebral venous thrombosis (CVT) is a rare but serious condition that can lead
to significant morbidity and mortality. Virchow's triad elucidates the role of blood …